Increased TNF-α and IL-1β levels in patients with PD–T2DM, which indicate aggravated inflammation, may explain the relationships between TNF-α, IL-1β, PD symptom duration and PDQ-39 scores in our study. This evidence concerns the gene IL1B and Parkinson disease.